Unique ID issued by UMIN | UMIN000000859 |
---|---|
Receipt number | R000001032 |
Scientific Title | Randomized, double blind, crossover clinical pharmacological study to evaluate the relationships between dose-, concentration in blood-, and sedative effect after histamine H1 receptor antagonist d-chlorpheniramine intake using saccadic eye movement analysis in healthy male volunteers |
Date of disclosure of the study information | 2007/10/20 |
Last modified on | 2010/02/17 20:45:12 |
Randomized, double blind, crossover clinical pharmacological study to evaluate the relationships between dose-, concentration in blood-, and sedative effect after histamine H1 receptor antagonist d-chlorpheniramine intake using saccadic eye movement analysis in healthy male volunteers
Evaluation of the sedative effect of histamine H1 receptor antagonist by eye movement analyzing system
Randomized, double blind, crossover clinical pharmacological study to evaluate the relationships between dose-, concentration in blood-, and sedative effect after histamine H1 receptor antagonist d-chlorpheniramine intake using saccadic eye movement analysis in healthy male volunteers
Evaluation of the sedative effect of histamine H1 receptor antagonist by eye movement analyzing system
Japan |
Healthy male volunteers
Not applicable |
Others
NO
The purpose of this study is evaluate relationships between dose-, concentration in blood, and sedative effect after histamine H1 receptor antagonist d-chlorpheniramine intake using saccadic eye movement analysis
PK,PD
Exploratory
Not applicable
Saccadic eye movement peak velocity
Visual analogue scale
Plasma concrntration of chlorpheniramine
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Dose comparison
NO
NO
Institution is not considered as adjustment factor.
YES
No need to know
3
Treatment
Medicine |
d-Chlorpheniramine maleate 1 mg single oral dose
d-Chlorpheniramine maleate 2 mg single oral dose
d-Chlorpheniramine maleate 4 mg single oral dose
20 | years-old | <= |
Not applicable |
Male
1. Healthy male volunteer
2. Subjects are competent to consent, keep the rules of the study and are able to report self condition
3.Subjects who are judged eligible by the investigator in several series of medical check
1. Inappropriate clinical history for medication study (i.e. drug abuse, alcoholism, diseases of heart, liver, kidney, lung, and blood etc.) or who are ambulatory patients suffering theses diseases.
2. Subjects who are ingested medicine with sedatives or antihistaminic agents during this study.
3. Smoker
4. Any history for drug allergy.
5. Severe alcoholism.
6. Subjects who are inadequate for enrollment judged by the investigator.
6
1st name | |
Middle name | |
Last name | Toshinori YAMAMOTO PhD. |
Showa University School of Pharmaceutical Sciences
Department of Clinical Pharmacy
1-5-8 Hatanodai Shinagawa-ku Tokyo 142-8555
1st name | |
Middle name | |
Last name | Noriko KOHYAMA PhD. |
Showa University School of Pharmaceutical Sciences
Department of Clinical Pharmacy
noriko-kyb@pharm.showa-u.ac.jp
Showa University School of Pharmaceutical Sciences
Department of Clinical Pharmacy
Grant-in Aid for Young Scientists (B)
Tsukuba Clinical Pharmacology Center Kan-nondai Clinic
Showa University School of Medicine Second Department of Pharmacology
NO
2007 | Year | 10 | Month | 20 | Day |
Unpublished
Completed
2007 | Year | 10 | Month | 09 | Day |
2007 | Year | 10 | Month | 01 | Day |
2007 | Year | 11 | Month | 01 | Day |
2007 | Year | 10 | Month | 19 | Day |
2010 | Year | 02 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001032